CAS No. |
2135632-29-8 |
|---|---|
英文名称 |
- |
别名 |
Atoltivimab;Research Grade Atoltivimab (DVV03606);Research Grade Atoltivimab;Atoltivimab (anti-EBOV) |
用途 |
Atoltivimab is a monoclonal antibody approved by the U.S. Food and Drug Administration (FDA) as part of the combination therapy with maftivimab and odesivimab (Inmazeb) for the treatment of Zaire ebolavirus (EBOV) infection. |
|
|
评论 |
|---|